First-in-Human Nanoparticles for Molecular Cancer Imaging

被引：0
|
作者：
不详
机构：
来源：
SCIENCE TRANSLATIONAL MEDICINE | 2014年 / 6卷 / 260期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Targeted Imaging of Esophageal Neoplasia with a Fluorescently Labeled Peptide: First-in-Human Results
    Sturm, Matthew B.
    Joshi, Bishnu P.
    Lu, Shaoying
    Piraka, Cyrus
    Khondee, Supang
    Elmunzer, Badih Joseph
    Kwon, Richard S.
    Beer, David G.
    Appelman, Henry D.
    Turgeon, Danielle Kim
    Wang, Thomas D.
    SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (184)
  • [22] First-in-human pilot study of a spatial frequency domain oxygenation imaging system
    Gioux, Sylvain
    Mazhar, Amaan
    Lee, Bernard T.
    Lin, Samuel J.
    Tobias, Adam M.
    Cuccia, David J.
    Stockdale, Alan
    Oketokoun, Rafiou
    Ashitate, Yoshitomo
    Kelly, Edward
    Weinmann, Maxwell
    Durr, Nicholas J.
    Moffitt, Lorissa A.
    Durkin, Anthony J.
    Tromberg, Bruce J.
    Frangioni, John V.
    JOURNAL OF BIOMEDICAL OPTICS, 2011, 16 (08)
  • [23] Molecular imaging and therapy of cancer with radiolabeled nanoparticles
    Hong, Hao
    Zhang, Yin
    Sun, Jiangtao
    Cai, Weibo
    NANO TODAY, 2009, 4 (05) : 399 - 413
  • [24] Stakeholder views on participant selection for first-in-human trials in cancer nanomedicine
    Satalkar, P.
    Elger, B. S.
    Shaw, D. M.
    CURRENT ONCOLOGY, 2016, 23 (06) : E530 - E537
  • [25] MucoUp® as a spacer in brachytherapy for uterine cervical cancer: A first-in-human experience
    Muramoto, Yoichi
    Murakami, Naoya
    Karino, Tatsuki
    Sugimoto, Satoru
    Takatsu, Jun
    Oshima, Masaki
    Kosugi, Yasuo
    Kawamoto, Terufumi
    Hirayama, Takashi
    Fujino, Kazunari
    Terao, Yasuhisa
    Shikama, Naoto
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2023, 42
  • [26] Collaborative, patient guided approach to a first-in-human study for advanced cancer
    Cockburn, Christine
    Evans, William
    Shackleton, Kylie
    Thomas, David
    Ameratunga, Malaka
    McPhee, Narelle
    Ervin-Haynes, Annette
    Sadou-Dubourgnoux, Amel
    Darcel, Pauline
    Rubio-Jareno, Ana
    Rakopoulos, Maryann
    Hinds, Francis
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 154 - 154
  • [27] First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer
    Dunphy, Mark P. S.
    Pressl, Christina
    Pillarsetty, Nagavarakishore
    Grkovski, Milan
    Modi, Shanu
    Jhaveri, Komal
    Norton, Larry
    Beattie, Bradley J.
    Zanzonico, Pat B.
    Zatorska, Danuta
    Taldone, Tony
    Ochiana, Stefan O.
    Uddin, Mohammad M.
    Burnazi, Eva M.
    Lyashchenko, Serge K.
    Hudis, Clifford A.
    Bromberg, Jacqueline
    Schoder, Heiko M.
    Fox, Josef J.
    Zhang, Hanwen
    Chiosis, Gabriela
    Lewis, Jason S.
    Larson, Steven M.
    CLINICAL CANCER RESEARCH, 2020, 26 (19) : 5178 - 5187
  • [28] Preclinical investigations and first-in-human application of 152Tb-PSMA-617 for PET/CT imaging of prostate cancer
    Mueller, Cristina
    Singh, Aviral
    Umbricht, Christoph A.
    Kulkarni, Harshad R.
    Johnston, Karl
    Bensova, Martina
    Senftleben, Stefan
    Mueller, Dirk
    Vermeulen, Christiaan
    Schibli, Roger
    Koester, Ulli
    van der Meulen, Nicholas P.
    Baum, Richard P.
    EJNMMI RESEARCH, 2019, 9 (1)
  • [29] Preclinical investigations and first-in-human application of 152Tb-PSMA-617 for PET/CT imaging of prostate cancer
    Cristina Müller
    Aviral Singh
    Christoph A. Umbricht
    Harshad R. Kulkarni
    Karl Johnston
    Martina Benešová
    Stefan Senftleben
    Dirk Müller
    Christiaan Vermeulen
    Roger Schibli
    Ulli Köster
    Nicholas P. van der Meulen
    Richard P. Baum
    EJNMMI Research, 9
  • [30] Synthesis, preclinical evaluation, and first-in-human study of Al18F-PSMA-Q for prostate cancer imaging
    Wu, Yitian
    Zhang, Xiaojun
    Zhou, Haoxi
    Xu, Baixuan
    Tian, Jiahe
    Sun, Shuwei
    Zhang, Jinming
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (08) : 2774 - 2785
12345